StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences gross margin

Gross margin is gross profit as a percentage of revenue.

Emmaus Life Sciences's gross margin for the twelve months ending Jun 30, 2026 was 93.6%. For fiscal 2025 it was 93.1%, against 92.8% the year before. The highest annual figure on record is 95.5% in fiscal 2023.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202593.1%+0.3
FY2024Dec 31, 202492.8%−2.7
FY2023Dec 31, 202395.5%+9.5
FY2022Dec 31, 202285.9%+2.0
FY2021Dec 31, 202183.9%−6.4
FY2020Dec 31, 202090.3%−4.9
FY2019Dec 31, 201995.2%+36.8
FY2017Sep 30, 201758.4%−35.2
FY2016Sep 30, 201693.5%−1.6
FY2015Sep 30, 201595.1%+49.1
FY2014Sep 30, 201446.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2026CQ2 2026Jun 30, 202694.6%+3.9
Q1 FY2026CQ1 2026Mar 31, 202691.5%−1.3
Q4 FY2025CQ4 2025Dec 31, 202593.9%−1.6
Q3 FY2025CQ3 2025Sep 30, 202592.7%+2.9
Q4 FY2024CQ4 2024Dec 31, 202490.6%−6.7
Q3 FY2024CQ3 2024Sep 30, 202492.8%−2.9
Q2 FY2024CQ2 2024Jun 30, 202495.5%+0.2
Q1 FY2024CQ1 2024Mar 31, 202489.7%−3.9
Q4 FY2023CQ4 2023Dec 31, 202397.3%+8.2
Q3 FY2023CQ3 2023Sep 30, 202395.7%+6.7
Q2 FY2023CQ2 2023Jun 30, 202395.3%+4.5
Q1 FY2023CQ1 2023Mar 31, 202393.6%+24.8
Q4 FY2022CQ4 2022Dec 31, 202289.1%+55.4
Q3 FY2022CQ3 2022Sep 30, 202289.1%−3.2
Q2 FY2022CQ2 2022Jun 30, 202290.8%−2.6
Q1 FY2022CQ1 2022Mar 31, 202268.9%−23.0
Q4 FY2021CQ4 2021Dec 31, 202133.7%−52.8
Q3 FY2021CQ3 2021Sep 30, 202192.3%+0.9
Q2 FY2021CQ2 2021Jun 30, 202193.4%+3.6
Q1 FY2021CQ1 2021Mar 31, 202191.8%−1.3
Q4 FY2020CQ4 2020Dec 31, 202086.6%−8.9
Q3 FY2020CQ3 2020Sep 30, 202091.4%−3.8
Q2 FY2020CQ2 2020Jun 30, 202089.8%+77.4
Q1 FY2020CQ1 2020Mar 31, 202093.1%+33.2
Q4 FY2019CQ4 2019Dec 31, 201995.5%+7.4
Q3 FY2019CQ3 2018Jun 30, 201995.2%+11.9
Q4 FY2017CQ3 2017Sep 30, 201712.4%−80.1
Q3 FY2017CQ2 2017Jun 30, 201759.9%−33.0
Q2 FY2017CQ1 2017Mar 31, 201788.1%−5.1
Q1 FY2017CQ4 2016Dec 31, 201683.3%−11.8
Q4 FY2016CQ3 2016Sep 30, 201692.5%−4.4
Q3 FY2016CQ2 2016Jun 30, 201692.9%−3.2
Q2 FY2016CQ1 2016Mar 31, 201693.2%+1.8
Q1 FY2016CQ4 2015Dec 31, 201595.1%−0.0
Q4 FY2015CQ3 2015Sep 30, 201596.9%–
Q3 FY2015CQ2 2015Jun 30, 201596.1%–
Q2 FY2015CQ1 2015Mar 31, 201591.4%–
Q1 FY2015CQ4 2014Dec 31, 201495.2%–

More Emmaus Life Sciences figures

See a number that looks wrong?